Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER2 | P43116 | 12/20 | 0.34 |
| ▸ | PTPRB | P23467 | 2/20 | 0.32 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.31 |
| ▸ | PRMT1 | Q99873 | 2/20 | 0.31 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.31 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL533417 | 0.89 | PTGER2 (0.35) | PTGER2F2 | |
| SCHEMBL534351 | 0.88 | PTGER2 (0.32) | PTGER2PTPRBCARM1PRMT1SCN8A | |
| SCHEMBL3458496 | 0.87 | ADRB2 (0.35) | PTGER2F2 | |
| SCHEMBL534184 | 0.86 | PPARA (0.34) | PTGER2PTPRBF2 | |
| SCHEMBL534126 | 0.82 | AAK1 (0.34) | PTGER2F2 | |
| SCHEMBL534340 | 0.82 | PTGER2 (0.33) | PTGER2CARM1PRMT1SCN8AGSTO1 | |
| SCHEMBL534341 | 0.81 | PTGER2 (0.51) | PTGER2 | |
| SCHEMBL533301 | 0.80 | PTGER2 (0.48) | PTGER2 | |
| SCHEMBL6525295 | 0.78 | PTGER2 (0.34) | PTGER2 | |
| SCHEMBL12982968 | 0.78 | PTGER2 (0.40) | PTGER2F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140113907-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2014-04-24 | — | — | US | disclosed |
| US-20110054172-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE CORPORATION (JP) | 2011-03-03 | — | — | US | disclosed |
| EP-2264009-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | Ube Industries, Ltd. (JP) | 2010-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140113907-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | PTGER2, PTGER1, PTGDR2 | PTGER2 1/4885PTPRB 2129/4885CARM1 3500/4885 |
| US-20110054172-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | PTGER2, PTGER1, PTGDR2 | PTGER2 1/4885PTPRB 2141/4885CARM1 3491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.